ОМ-85: Personalized approach to the treatment of acute respiratory infections in children

Personalized immunotherapy ensures good treatment results in difficult patients with acute respiratory infections (ARIs). The main indication for such therapy is the phenotype of a ‘patient with recurrent ARIs’ (immunocompromised patient) associated with multiple complications. Bacterial lysate OM-85 is a first-line immunomodulatory agent for patients with recurrent respiratory infections within the treatment and prevention of ARI episodes. OM-85 decreases the frequency of ARI episodes, severity of clinical manifestations, and disease duration, prevents excessive pharmacological load, and reduces the number of complication. © 2020, Dynasty Publishing House. All rights reserved.